$Biorestorative Therapies(BRTX.US)
News
BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform | BRTX Stock News
Biorestorative Therapies
BRTX----
Biorestorative Therapies (BRTX)
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The com...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Biorestorative Therapies Analyst Rating
View MoreForecast & Rating
Apr 8, 2026Price forecast
$8.002658.62%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 2 hours ago
BioRestorative Therapies files Form 3 initial beneficial ownership statement for director Steven Collier Brown
- benzinga_article · Jul 8 at 04:05 PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
- PUBT · Jun 25 at 07:15 AM
BioRestorative completes Phase 2 manufacturing for BRTX-100 lumbar disc disease trial supply
- StockTitan · Jun 24 at 11:15 PM
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform | BRTX Stock News
- PUBT · Jun 18 at 11:40 AM
BioRestorative Therapies files Form 3 for director Jatinder Dhaliwal, reporting no beneficial ownership
- Unusual Whales · Jun 18 at 07:16 AM
Zachary Smith appointed VP of Biocosmeceuticals at BioRestorative Therapies to drive growth and expansion.
Posts
View MoreBullish vs. Bearish — Last 3 Months
221 followers · 0 opinions
▲Bullish50%
50%Bearish▼
